HK1220393A1 - 含有經穩定化的 -氨基- -溴苯甲醯基 苯乙酸的水性組合物 - Google Patents

含有經穩定化的 -氨基- -溴苯甲醯基 苯乙酸的水性組合物

Info

Publication number
HK1220393A1
HK1220393A1 HK16108544.6A HK16108544A HK1220393A1 HK 1220393 A1 HK1220393 A1 HK 1220393A1 HK 16108544 A HK16108544 A HK 16108544A HK 1220393 A1 HK1220393 A1 HK 1220393A1
Authority
HK
Hong Kong
Prior art keywords
bromobenzoyl
amino
composition containing
aqueous composition
phenylacetic acid
Prior art date
Application number
HK16108544.6A
Other languages
English (en)
Inventor
岡本智之
山口真生
Original Assignee
Santen Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Santen Pharmaceutical Co Ltd filed Critical Santen Pharmaceutical Co Ltd
Publication of HK1220393A1 publication Critical patent/HK1220393A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0046—Ear
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Otolaryngology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HK16108544.6A 2013-09-26 2016-07-19 含有經穩定化的 -氨基- -溴苯甲醯基 苯乙酸的水性組合物 HK1220393A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2013199442 2013-09-26
PCT/JP2014/075342 WO2015046281A1 (ja) 2013-09-26 2014-09-25 安定化された２－アミノ－３－（４－ブロモベンゾイル）フェニル酢酸含有水性組成物

Publications (1)

Publication Number Publication Date
HK1220393A1 true HK1220393A1 (zh) 2017-05-05

Family

ID=52743415

Family Applications (1)

Application Number Title Priority Date Filing Date
HK16108544.6A HK1220393A1 (zh) 2013-09-26 2016-07-19 含有經穩定化的 -氨基- -溴苯甲醯基 苯乙酸的水性組合物

Country Status (5)

Country Link
JP (1) JP2015086222A (zh)
CN (1) CN105451731B (zh)
HK (1) HK1220393A1 (zh)
TW (1) TW201601717A (zh)
WO (1) WO2015046281A1 (zh)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019117252A1 (ja) * 2017-12-14 2019-06-20 参天製薬株式会社 ２－アミノ－３－（４－ブロモベンゾイル）フェニル酢酸またはその塩を含有する点眼剤

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090215735A1 (en) * 2002-02-25 2009-08-27 Alcon, Inc. Topical solution formulations containing a corticosteroid and a cyclodextrin
ES2295647T3 (es) * 2002-07-15 2008-04-16 Alcon, Inc. Composiciones de implante farmaceuticas lipofilas, no polimeras, para uso intraocular.
CN100341498C (zh) * 2003-01-21 2007-10-10 千寿制药株式会社 含有2－氨基－3－(4－溴苯甲酰基)苯乙酸的水成液制剂
KR20130080061A (ko) * 2004-11-05 2013-07-11 센주 세이야꾸 가부시키가이샤 안구 내 이행성 촉진 수성 점안제
AR063621A1 (es) * 2006-11-09 2009-02-04 Alcon Res Ltd Matriz polimerica insoluble en agua para la administracion de farmacos
CN101313899B (zh) * 2007-06-01 2012-02-29 北京德众万全药物技术开发有限公司 一种含有溴芬酸钠的眼用药物组合物
JP2009161454A (ja) * 2007-12-28 2009-07-23 Lion Corp 眼科用組成物
WO2012099142A1 (ja) * 2011-01-18 2012-07-26 千寿製薬株式会社 保存効力を有するブロムフェナク水性液剤組成物

Also Published As

Publication number Publication date
CN105451731B (zh) 2019-01-18
TW201601717A (zh) 2016-01-16
CN105451731A (zh) 2016-03-30
JP2015086222A (ja) 2015-05-07
WO2015046281A1 (ja) 2015-04-02

Similar Documents

Publication Publication Date Title
IL277652B (en) Stable aqueous formulations of adlimumab
HK1224226A1 (zh) 與間水楊酸形成的烟鹼鹽
HK1211569A1 (zh) 氨基酸衍生物
SG11201603144QA (en) Artificial nucleic acid molecules
EP3919505C0 (en) USES OF CAS9 NUCLEIC ACID COMPLEXES
EP2971161A4 (en) NUCLEIC CLEANING
HK1225372A1 (zh) 氨基酸衍生物
IL235425B (en) History of lysine-glutamic acid di-peptide
RU2016118399A3 (en) 4-aminomethylbenzoic acid derivative
EP3041354A4 (en) Substituted hydroxamic acid compounds
GB201419367D0 (en) Nucleic acid probe
EP2970325A4 (en) LYSOPHOSPHATIDE ACID DETECTION
EP2975022A4 (en) NOVEL HYDROXAMINE ACID DERIVATIVE OR SALT THEREOF
DK2865275T3 (da) Foderstofadditiv indeholdende L-aminosyre
EP2999341A4 (en) STABILIZED HYPOCHLORIC ACID SOLUTION AND USE THEREOF
EP2994745A4 (en) ELECTROCHEMICAL PH MEASUREMENT
HK1212978A1 (zh) 芥子酸的新型衍生物
IL240050A0 (en) Agricultural chemical composition in the form of an aqueous suspension
PL2919755T3 (pl) Wodna ciekła kompozycja zawierająca kwas 2-amino-3-(4-bromobenzoilo)fenylooctowy
DK2865274T3 (da) Foderstofadditiv indeholdende L-aminosyre
SG11201405837YA (en) Aqueous composition containing 2-amino-3-(4-bromobenzoyl)- phenylacetic acid
EP2952190A4 (en) STABLE AYE SOLUTION
SG10201401381SA (en) Acid injection
HK1220393A1 (zh) 含有經穩定化的 -氨基- -溴苯甲醯基 苯乙酸的水性組合物
BR112016008807A2 (pt) usos de um ácido nucleico

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20230924